BillionToOne, Inc.
NASDAQ:BLLNMedical - Diagnostics & Research
+$0.84 today
- Market cap
- $4.37B
- Beta
- 0.90
- P/E (TTM)
- 182.6
- EPS (TTM)
- $0.55
Volume 1.44M
Average 0.59M
BLLN Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
BillionToOne, Inc.NASDAQ: BLLN
Accumulated OCI · Q2 FY2026 · quarter ended Jun 2026
Accumulated OCI turns negative
Q2 FY2026 Accumulated OCI was -$1.79M, compared with $0 a year earlier.
Context
- Accumulated OCI amounted to 0.2% of total assets at the end of Q2 FY2026, up 0.2 pp from a year earlier.
- Accumulated OCI increased in 0 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Accumulated OCI history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Accumulated OCI | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
Accumulated OCI vs competitors
How BLLN compares with its peers on the latest reported figures
- BLLN's Jun 2026 Accumulated OCI of -$1.79M is the 7th highest of the 9 companies compared; the peer median is $173K.
- Accumulated OCI amounts to 0.2% of total assets for BLLN, versus a peer median of 0.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $4.54M | +4.6% | — | 0.4% | |
| Jun 2026 | $1.84M | -20.1% | +43.7% | 0.1% | |
| Mar 2026 | $700K | +216.7% | — | 0.1% | |
WGSGeneDx Holdings Corp. | Jun 2026 | $342K | -57.9% | — | 0.1% |
| Jun 2026 | $4K | -86.2% | — | 0.0% | |
| Jun 2026 | -$108K | +62.4% | — | 0.0% | |
BLLNBillionToOne, Inc. | Jun 2026 | -$1.79M | — | — | 0.2% |
| Sep 2026 | -$5.13M | -20.5% | — | 0.3% | |
| Jun 2026 | -$7.94M | +33.6% | — | 0.5% | |
| Peer median (excluding BLLN) | $173K | -7.7% | +43.7% | 0.1% | |
Competitors are the stored peer set for BLLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
BillionToOne, Inc.
NASDAQ:BLLN
Intrinsic Alpha fair value
Locked
Current Price
$91.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.